Puma Biotechnology, Inc.

Yield per half year: +16.01%
Dividend yield: 0%
Sector: Healthcare

Puma Biotechnology, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
5.08 33.49 -84.84% 41.17 -87.67%
P/S 0.67 129.83 -99.49%
P/BV 1.67 260.15 -99.36%
P/FCF 6.56 -180.12 -103.64%
Ev/Ebitda 3.3 -28.84 -111.44%
Ev/S 0.69 548.04 -99.87%
Ev/FCF 4.08 -289.87 -101.41%
E/P 0.12 0.0228 421.68%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
20.86 -375.54 -105.55% 18.39 +13.44%
ROE 41.6 106.63 -60.98%
ROA 13.64 -2.32 -689.29%
ROIC -32.16 0.83 -3954.86%
ROS 13.14 -298.59 -104.4%
ROCE 39.68 3.17 1150.76%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.54 0.94 63.47% 2.48 -37.96%
Nеt Debt/Ebitda 0.1 1.04 -90.32%
Debt/Ratio 0.35 0.18 93.17%
Debt/Equity 1.32 1.62 -18.76%
Debt/Net Income 2.45 -1.65 -248.13%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.53 -100% 0 0%
Number of years of dividend growth 0 0.82 -100%
DSI 0 0.21 -100%
Average dividend growth 0 2.29 -100%
Average percentage for 5 years 0 0.52 -100%
Average percentage for payments 0 58.77 -100%
Difference from average difference in sector -0.53

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
2.38 -99.58 -102.39%
Growth impulse Ebitda in 5 years -262.97 -152.61 72.32%
Growth impulse Net Income in 5 years -150.46 -115.25 30.55%
Growth impulse FCF in 5 years -302.41 -161.2 87.6%
Growth impulse EPS in 5 years -140.57 -106.31 32.23%
IP Score
4.74/10

Similar companies

Alexion

ABIOMED

Gilead Sciences

Amgen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription